Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2008.366 | Open-Label Extension Study of 23 mg Donepezil SR in Patients with Moderate to Severe Alzheimer | Prof. Mok C.T. Vincent |
| 2017.257 | Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis (NASH) |
Prof. WONG Vincent Wai Sun 黃煒燊 |
| 2006.368 | Open-Label Study of Bevacizumab (Avastin_) Plus Taxane Monotherapy or in Combination for the First-Line Treatment of Patients with Locally Recurrent or Metastatic Breast Cancer ATHENA (Avastin THErapy for advaNced bresAst cancer) | Dr. Ho Wing Ming |
| 2016.597 | Open-Label, Randomized Trial of Nivolumab (BMS-936558) plus Pemetrexed/Platinum or Nivolumab plus Ipilimumab (BMS-734016) vs Pemetrexed plus Platinum in Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC) Subjects with Epidermal Growth Factor Receptor (EGFR) Mutation Who Failed 1L or 2L EGFR Tyrosine Kinase Inhibitor Therapy |
Prof. MOK Tony Shu Kam 莫樹錦教授 |
| 2016.688 | Open-Label, Single Arm, Phase 3b, Multi-Center Study Evaluating the Impact of Venetoclax on the Quality of Life of Relapsed/Refractory Subjects with Chronic Lymphocytic Leukemia (CLL) Including Those with the 17p Deletion or TP53 Mutation OR Those Who Have Received Prior Treatment with a B-Cell Receptor Inhibitor |
Dr. WONG Raymond Siu Ming 王紹明醫生 |
| 2015.087 | Open-label, uncontrolled Phase II trial of intravenous PI3K inhibitor BAY 80-6946 in patients with relapsed, indolent or aggressive Non-Hodgkin’s lymphomas (Part B) | Dr. WONG Raymond Siu Ming |
| 2004.314 | Open, Randomized, Controlled, Multicenter Phase III Study Comparing 5-FU/FA Plus Irinotecan Plus Cetuximab Versus 5-FU/FA Plus Irinotecan as First-Line Treatment for Epidermal Growth Factor Receptor | Prof. Chan Tak Cheung Anthony |
| 2021.135 | Operative Mortality After Triple Valve Surgery: Prognostic Value of Simplified MELD-Na | Dr. LIM Kevin |
| 2019.618 | Opioid analgesics during and following radiotherapy treatment of head and neck tumours | Dr. CHAN Jason Ying Kuen |
| 2015.718 | Opt-out HIV testing in out-patient setting | Prof. TAM Greta Chun Huen |
| 2004.081 | Optical Brian Imaging of Incidental and Intentional Memory Retrieval | PENNEY Trevor |
| 2021.505 | Optical coherence tomography (OCT) for lung imaging |
Dr. YUAN Wu 袁武 |
| 2021.273 | Optical Coherence Tomography and Optical Coherence Tomography Angiography features in Cytomegalovirus Retinitis | Dr. WONG Po Yin |
| 2017.358 | Optical Coherence Tomography evaluation of Bioabsorbable Vascular Scaffold Technique with Magmaris | Prof. YAN Bryan Ping Yen |
| 2015.297 | Optical Coherence Tomography evaluation of Very Early eNdothelialization after Dual Therapy Drug-eluting Stent with EPC CaptURE (OCT-VENTURE) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.291 | Optimal Bioabsorbable Vascular Scaffold Technique for Complex Bifurcation Lesions |
Dr. YAN Bryan Ping Yen 甄秉言 |
| 2025.277 | Optimal Cancer Screening Strategy for Nasopharyngeal Carcinoma (NPC) by combining Epstein-Barr Virus (EBV) Antibodies, DNA, and Nasal Endoscopy EB 病毒抗体,核酸及鼻内窥镜检查相结合的鼻咽癌最优早筛策略研究 | Dr. LAM Jacky Wai Kei |
| 2024.134 | Optimal Dosage of Atropine and Red Light Combination Therapy for Myopia Treatment (LAMP-4) Study | Prof. YAM Jason Cheuk Sing |
| 2019.245 | Optimal proximal interphalangeal joint position for treatment of mallet finger: a cadaveric biomechanical study |
Dr. MAK Suk Ying 麥淑楹 |
| 2020.224 | Optimal Strategy for the Monitoring of Dialysis Adequacy in Peritoneal Dialysis Patients |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2005.442 | Optimal Time of Laparoscopic Cholecystectomy After Endoscopic Clearance of Endoscopic Bile Duct Stone Removal in Acute Cholangitis | Prof. NG Kwok Wai |
| 2017.240 | Optimal timing of umbilical cord clamping for term babies with natural birth – a randomised open-labelled trial |
Prof. TAM Wing Hung 譚永雄 |
| 2004.302 | Optimal Ventricular Resynchronization and Nt-proBNP in Heart Failure Therapy | Prof. Yu Cheuk Man |
| 2005.121 | Optimisation of Antihypertensive Therapies: Application of Pharmacogenomic and Biochemical Technologies ptimisation of Antihypertensive Therapies: Application of Pharmacogenomic and Biochemical Technologies | Prof. Brian Tomlinson |
| 2009.217 | Optimise CRT | Professor Yu Cheuk-Man |
| 2024.680 | Optimising the use of anti-CD20 therapy in childhood frequently relapsing, steroid-dependent nephrotic syndrome: the B-cell therapy Exploration Group for Idiopathic Nephrotic Syndrome study (BEGINS) | Dr. CHAN Eugene Yu Hin |
| 2018.132 | Optimization of antibiotics treatment duration in bloodstream infections with a serum procalcitonin-based algorithm |
Dr. LI Timothy Chun Man 李俊文 |
| 2014.270 | Optimization of culture method for human adipose derived-msenchymal stem cells with minimal amount of fetal bovine serum | Prof. POON Wai Sang |
| 2022.159 | Optimization of Peritoneal Dialysis Prescription by Early Determination of Peritoneal Transport Characteristics |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2020.601 | Optimization of Urine Processing for Biomarker Development of Kidney Diseases |
Prof. SZETO Cheuk Chun 司徒卓俊 |
| 2021.238 | Optimizing Predictions of Dyslexia Cross-Culturally: Chinese and English Compared | Prof. MCBRIDE Catherine |
| 2017.001 | Optimizing varices screening in cirrhotic patients with well-controlled chronic viral hepatitis: A prospective cohort study with transient elastography and multiparametric magnetic resonance imaging |
Dr. WONG Vincent Wai Sun 黃煒燊 |
| 2014.053 | Oral 5-aminosalicyclic Acid Withdrawal in Long Standing Inactive Ulcerative Colitis: A Double-blind, Randomized, Placebo-controlled Trial | Prof. NG Siew Chien |
| 2013.482 | Oral Arsenic trioxide in Management of Newly Diagnosed and Relapsed or refractory Acute Promyelocytic Leukemia (PML/RARα) in Children | Dr. LI Chi Kong |
| 2010.368 | Oral feeding performance in infants | NG Sze Ka |
| 2004.058 | Oral Health Survey in Psychiatric Patients in Hong Kong | UNGVARI Gabor S |
| 2011.171 | Oral motor skills in children with speech sound disorders of unknwn origin: a comparison with children normal speech | Prof Lee Kathy |
| 2023.529 | Orbital RadiothErapy, Sirolimus and Intravenous steroid for Primary Diplopia in Thyroid Eye Disease (RESIDE): a multi-center, double-masked, sham- and placebo-controlled randomized trial | Dr. CHAN Karen Kar Wun |
| 2010.548 | Orbitofrontal gray matter volume among adult female patients with major depressive disorder | Prof Tang Wai Kwong |
| 2021.605 | ORGAN-SPECIFIC RESPONSES TO ATEZOLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: A MULTINATIONAL MULTICENTER STUDY |
Prof. CHAN Stephen Lam 陳林教授 |
| 2021.681 | Origin and evolutionary adaptation of the carcinogenicity of human papillomaviruses: evaluation of human and non-human primate PV E6 and E7 oncogenes interacting with host proteomes |
Prof. CHEN Zigui 陳子桂 |
| 2013.138 | Orphan nuclear receptor estrogen-related receptor alpha (ERRa): functional roles and potential therapeutic targeting in hormone-dependent and -independent prostate and breast cancers | Professor Chan Leung Franky |
| 2009.554 | Oseltamivir pharmacokinetics in critically ill patients with normal and increased creatinine clearance | CHOI Gordon |
| 2018.288 | Osteoarthritis tissue characteristics and its correlation with patient's clinical performance and symptomatology |
Dr. LAU Lawrence Chun Man 劉振民 |
| 2014.198 | Osteocytes, the missing link to abnormal bone mineralization and bone microarchitecture in Adolescent Idiopathic Scoliosis | Prof. CHENG Jack Chun Yiu |
| 2011.440 | Osteonecrosis of the Jaw in patients on oral bisphosphonate for osteoporosis | KWOK Timothy |
| 2003.102 | Osteoporotic Fractures in Chinese Men: Mr. Os Hong Kong | Prof. LEUNG Ping Chung |
| 2022.151 | Osteosarcopenia Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) and fracture risk in non-osteoporotic patients with immune-mediated inflammatory disease |
Prof. TAM Lai Shan 譚麗珊 |
| 2019.336 | Osteoscopic Assisted Excision of Enchondroma in the Hand |
Dr. MAK Michael Chu Kay 麥柱基 |
| 2022.112 | Our Ten Years’ Experience in Total Wrist Replacement | Dr. WAN Raymond Chung Wai |
Page 179 of 265.